Dayna Field - ALS General Secretary
| ALQ Stock | 15.50 0.66 4.08% |
Executive
Dayna Field is General Secretary of ALS
| Address | 25 King Street, Brisbane, QLD, Australia, 4006 |
| Phone | 61 7 3367 7900 |
| Web | https://www.alsglobal.com |
ALS Management Efficiency
The company has return on total asset (ROA) of 0.0832 % which means that it generated a profit of $0.0832 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0117 %, meaning that it generated $0.0117 on every $100 dollars invested by stockholders. ALS's management efficiency ratios could be used to measure how well ALS manages its routine affairs as well as how well it operates its assets and liabilities. Total Current Liabilities is likely to gain to about 894.1 M in 2024. Liabilities And Stockholders Equity is likely to gain to about 3.9 B in 2024Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| CFA CFA | Platinum Asia Investments | N/A | |
| Kimberley Menzies | Nova Eye Medical | N/A | |
| Merricc EdgarHughes | EMvision Medical Devices | N/A | |
| Mark Flynn | Nova Eye Medical | N/A | |
| Simon Dutton | Clime Investment Management | N/A | |
| Robert Tiller | EMvision Medical Devices | N/A | |
| Tushar Kale | Clime Investment Management | N/A | |
| MBA CFA | Platinum Asia Investments | N/A | |
| Kara Boden | Clime Investment Management | N/A | |
| Xun Wang | Clime Investment Management | N/A | |
| James Trude | Clime Investment Management | N/A | |
| David MD | Nova Eye Medical | N/A | |
| Don Watton | Nova Eye Medical | N/A | |
| Kerry Thomas | Clime Investment Management | N/A | |
| BSc FAICD | Nova Eye Medical | 66 | |
| Keith Byrne | Nova Eye Medical | N/A | |
| James CA | Diversified United Investment | N/A | |
| BEc CA | Nova Eye Medical | 65 | |
| Kate Hunt | Nova Eye Medical | N/A | |
| BCom BCOMMLLB | Platinum Asia Investments | N/A | |
| Vincent Chin | Clime Investment Management | N/A | |
Management Performance
| Return On Equity | 0.0117 | ||||
| Return On Asset | 0.0832 |
ALS Leadership Team
Elected by the shareholders, the ALS's board of directors comprises two types of representatives: ALS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ALS. The board's role is to monitor ALS's management team and ensure that shareholders' interests are well served. ALS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ALS's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tim Kilmister, Gen APAC | ||
| Kristen Walsh, Gen Industrial | ||
| MBA BScHon, Gen Geochemistry | ||
| ACIS BA, G Sec | ||
| Luis Damasceno, Chief Officer | ||
| Malcolm Deane, MD CEO | ||
| GradDip Sc, Chief Officer | ||
| MBA Bus, Global HR | ||
| BSc BA, CEO MD | ||
| Dayna Field, General Secretary | ||
| Heike Truol, Chief Officer | ||
| CPA Bus, Group Controller | ||
| Andreas Jonsson, Gen EMEA |
ALS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ALS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0117 | ||||
| Return On Asset | 0.0832 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 9.59 B | ||||
| Shares Outstanding | 484.57 M | ||||
| Shares Owned By Insiders | 2.04 % | ||||
| Shares Owned By Institutions | 40.70 % | ||||
| Price To Book | 6.91 X | ||||
| Price To Sales | 3.18 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ALS Stock Analysis
When running ALS's price analysis, check to measure ALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ALS is operating at the current time. Most of ALS's value examination focuses on studying past and present price action to predict the probability of ALS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ALS's price. Additionally, you may evaluate how the addition of ALS to your portfolios can decrease your overall portfolio volatility.